The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the company's stock price and raised concerns about the safety data and regulatory pathway for BMB-101. Bright Minds disputes the FDA's interpretation but acknowledges potential delays and additional requirements. An investigation is ongoing into possible securities law violations, offering investors who suffered losses a chance to seek recovery.
Bright Minds Biosciences investigation notice provides context for readers following health-sector stocks. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:41 WIB: out of 150 priced US health stocks, 49 rose and 99 fell. Notable movers include Ginkgo Bioworks Holdings Inc (DNA) at USD 9.81 with a 12.60% drop, 10X Genomics Inc (TXG) at USD 61.78 down 11.88%, and SELLAS Life Sciences Group Inc (SLS) at USD 8.57 down 11.38%.
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
NEAR governance approved a plan to reduce the maximum annual issuance of the NEAR token from 2.5% to 1.6%. This change aims to slow the rate at which new tokens enter circulation, potentially impacting staking rewards by lowering them. The plan inclu...
Citi Wealth released a report titled "Expanding the Investable Universe: Introduction to Crypto ETFs," which explores spot Bitcoin and Ether exchange-traded funds (ETFs) as viable options for diversifying investment portfolios. The report positions t...
